|  | Analysis of mediansa | Analysis of pooled average | ||
---|---|---|---|---|---|
Clinically important difference | Range | Number of studies (patientsb) | MCID median (IQR) | Number of studies (patientsb) | MCID pooled average (95% CI), I2 c |
Minimum clinically important difference for pain relief | |||||
 Absolute change, mm | |||||
  Mean change approach | 8 to 40 | 29 (6517) | 17 (14 to 23) | 23 (6024) | 17 (15 to 19), 93% |
  Threshold approach | 10 to 35 | 6 (2331) | 10 (10 to 10) | NA | NA |
 Relative change, % | |||||
  Mean change approach | 13 to 85 | 14 (1617) | 23 (18 to 36) | 11 (1397) | 22 (19 to 26), 75% |
  Threshold approach | 15 to 50 | 4 (534) | 50 (33 to 50) | NA | NA |
Substantial clinically important difference for pain relief | |||||
 Absolute change, mm | |||||
  Mean change approach | 18 to 54 | 23 (6114) | 32 (24 to 38) | 21 (5891) | 32 (27 to 38), 97% |
 Relative change, % | |||||
  Mean change approach | 36 to 78 | 11 (1397) | 57 (45 to 65) | 11 (1397) | 57 (47 to 67), 94% |
Minimum clinically important difference for pain worsening | |||||
 Absolute change, mm | |||||
  Mean change approach | −21 to –8 | 18 (3822) | −11 (–13 to –10) | 16 (3644) | −12 (–14 to –11), 62% |
 Relative change, % | |||||
  Mean change approach | −89 to –17 | 7 (918) | −44 (–90 to –16) | 7 (918) | −35 (–47 to –23), 67% |
Substantial clinically important difference for pain worsening | |||||
 Absolute change, mm | |||||
  Mean change approach | −66 to 0 | 16 (3663) | −21 (–28 to –16) | 14 (3464) | −24 (–29 to –18), 71% |
 Relative change, % | |||||
  Mean change approach | −292 to –18 | 7 (918) | −83 (–292 to –18) | 7 (918) | −34 (–49 to –19), 20% |